Should I Buy REGN Stock in 2026?
Data-driven analysis and honest assessment for Regeneron Pharmaceuticals Inc
Current Price: $781.67P/E: 18.6
Decision Score
Weak
Based on 6 fundamental factors
Score Breakdown:
Reasonable P/E of 18.6
Declining -0%
Thin margins (0% net)
Financial health data limited
Decent FCF yield of 3.6%
No recent insider activity
Key Investment Metrics
Current Price
$781.67
P/E Ratio
18.59
Revenue Growth
0.0%
Profit Margin
0.3%
Market Cap
$81.5B
Dividend Yield
0.00%
How REGN Compares to Competitors
Understanding how REGN stacks up against peers helps inform your investment decision.
How REGN Compares to Peers
Upcoming Events for REGN
+5 Reasons TO Buy REGN
Limited data available to identify compelling buy reasons. Consider this a yellow flag.
-5 Reasons NOT to Buy REGN
1. Thin profit margins of 0.3%
high riskLow margins provide little cushion against cost increases or pricing pressure.
2. Minimal revenue growth
low riskGrowth of 0.0% barely keeps pace with inflation.
Who Should Buy REGN?
Investment Profile
Risk Level
Medium
Recommended Holding Period
3-5 years
Best For:
Not Suitable For:
- ✗
Growth Investors
Limited 0% growth may disappoint
- ✗
Income-Focused Retirees
Low 0.0% yield
Consider These Alternatives
If you're interested in REGN, compare these Health Care peers:
Pro tip: Compare REGN directly with competitors using our comparison tool to see which stock better fits your criteria.
Get the Full Picture
Access AI-powered insights, DCF valuations, insider trading data, and real-time analysis for REGN
Frequently Asked Questions
What is REGN stock price today?
REGN (Regeneron Pharmaceuticals Inc) stock is trading at $781.67 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).
Is REGN stock going up or down today?
REGN stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.
Should I buy REGN stock now?
The decision to buy REGN depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.
Is REGN a buy, hold, or sell right now?
Our AI-powered analysis provides buy/hold/sell recommendations for REGN based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.
Is REGN stock overvalued or undervalued?
REGN currently trades at a P/E ratio of 18.59 relative to earnings. Our DCF calculator provides intrinsic value estimates to help determine if REGN is fairly priced.
What is REGN's P/E ratio?
REGN has a price-to-earnings (P/E) ratio of 18.59, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.
What is REGN's market cap?
REGN (Regeneron Pharmaceuticals Inc) has a market capitalization of $81.49 billion, making it a mid-cap stock.
What is REGN's price to book ratio?
REGN trades at a price-to-book (P/B) ratio of 2.12, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.
Deep Dive Analysis
Explore comprehensive analysis tools to make an informed decision about Regeneron Pharmaceuticals Inc
Full Stock Analysis
Complete REGN overview with charts and data
Is REGN Undervalued?
DCF valuation and intrinsic value analysis
Dividend Analysis
Yield, payout ratio, and dividend history
Growth Analysis
Revenue, earnings, and expansion metrics
Financial Health
Debt, liquidity, and balance sheet strength
Price Prediction
2026 forecast and price targets
Stock Forecast
12-month price forecast and analyst targets
Earnings Date
Next earnings date and historical results
Compare Before You Buy
See how REGN stacks up against its competitors
Similar Investment Decisions
Explore investment analyses for stocks similar to Regeneron Pharmaceuticals Inc
Complete REGN Analysis
Compare REGN With
Disclaimer
This analysis is for informational purposes only and should not be considered financial advice. The decision score and recommendations are based on quantitative factors and do not account for all risks, your personal financial situation, or qualitative factors. Always do your own research and consider consulting with a financial advisor before making investment decisions.